You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

How I Treat: Through the Spectrum of Congenital Thrombotic Thrombocytopenic Purpura

  • Authors: Johanna A. Kremer Hovinga, MD; Spero R. Cataland, MD; Marie Scully, MD, MBE; Paul Coppo, MD, PhD
  • CPD Released: 8/24/2022
  • Valid for credit through: 8/24/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.50 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for non-US hematology specialists, emergency medicine physicians, critical care specialists, obstetricians/gynecologists, and other members of the healthcare team involved in the management of patients with congenital thrombotic thrombocytopenic purpura (cTTP).

The goal of this activity is that learners will be better able to implement appropriate management approaches for different situations in patients with cTTP.

Upon completion of this activity, participants will:

  • Have greater competence related to
    • Determining management approaches in difficult cTTP cases
    • Addressing subacute cTTP symptoms
    • Mitigating long-term complications associated with cTTP


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Disclosures for additional planners can be found here.


Faculty

  • Johanna A. Kremer Hovinga, MD

    Professor of Hematology
    Department of Hematology and Central Hematology Laboratory
    Bern University Hospital, University of Bern
    Bern, Switzerland

    Disclosures

    Johanna A. Kremer Hovinga, MD, has the following relevant financial relationships:
    Consultant or advisor for: Bayer; Novo Nordisk; Octapharma; Roche; Sanofi; Sobi; Takeda
    Speaker or member of speakers bureau for: CSL Behring; Novo Nordisk; Roche; Sanofi; Siemens; Takeda
    Research funding from: Baxalta US, Inc.; Bayer; CSL Behring; Novo Nordisk; Octapharma; Roche; Sobi; Takeda

  • Spero R. Cataland, MD

    Professor of Internal Medicine
    Section Head, Benign Hematology
    Division of Hematology
    Ohio State University
    Columbus, Ohio, United States

    Disclosures

    Spero R. Cataland, MD, has no relevant financial relationships.

  • Marie Scully, MD, MBE

    Professor of Hemostasis and Thrombosis
    University College London
    Clinical Lead Hematopathology and Blood Transfusion
    University College London Hospitals
    London, United Kingdom

    Disclosures

    Marie Scully, MD, MBE, has the following relevant financial relationships:
    Consultant or advisor for: Alexion; Novartis; Sanofi; Takeda
    Speaker or member of speakers bureau for: Alexion; Novartis; Octapharma; Sanofi; Takeda
    Research funding from: Alexion; Shire

  • Paul Coppo, MD, PhD

    Professor of Hematology
    Sorbonne University
    Head, French Reference Center for Thrombotic Microangiopathies
    Department of Hematology
    Saint-Antoine Hospital
    Paris, France

    Disclosures

    Paul Coppo, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Alexion; Sanofi; Takeda
    Speaker or member of speakers bureau for: Alexion; Sanofi; Takeda
    Research funding from: Alexion; Roche; Sanofi

Editors

  • Keisha Peters, MSc

    Medical Education Director, WebMD Global, LLC 

    Disclosures

    Keisha Peters, MSc, has no relevant financial relationships.

  • Chii Shyang Fong, PhD

    Scientific Content Manager, WebMD Global, LLC 

    Disclosures

    Chii Shyang Fong, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

How I Treat: Through the Spectrum of Congenital Thrombotic Thrombocytopenic Purpura

Authors: Johanna A. Kremer Hovinga, MD; Spero R. Cataland, MD; Marie Scully, MD, MBE; Paul Coppo, MD, PhDFaculty and Disclosures

CPD Released: 8/24/2022

Valid for credit through: 8/24/2023

processing....

Contents of This CPD Activity

All sections of this activity are required for credit.

Selecting a Treatment for a Patient With Severe cTTP: Balancing Burden of Disease and Burden of Treatment

Dr Kremer Hovinga discusses when and how patients with severe cTTP should be treated.
Johanna A. Kremer Hovinga, MD

Managing a Patient With Refractory cTTP

Dr Cataland shares advice on treating patients with refractory cTTP.
Spero R. Cataland, MD

Managing Patients With cTTP Between Acute Phases of Disease, Experiencing Subacute Symptoms: A Patient Case

Dr Scully presents management strategies for patients with subacute cTTP symptoms.
Marie Scully, MD, MBE

Addressing Long-Term cTTP-Related Complications: CVD and Renal Complications

Dr Coppo provides perspectives on chronic organ involvement in patients with cTTP.
Paul Coppo, MD, PhD
 

Educational Impact Challenge

The goal of this activity is that learners will be better able to Implement appropriate management approaches for different situations in patients with cTTP.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.